Iradimed (NASDAQ:IRMD) Given Buy Rating at Roth Mkm
Roth Mkm reissued their buy rating on shares of Iradimed (NASDAQ:IRMD – Free Report) in a report issued on Friday morning,Benzinga reports. The brokerage currently has a $72.00 price target on the medical equipment provider’s stock, up from their previous price target of $60.00. Separately, StockNews.com lowered shares of Iradimed from a “strong-buy” rating to […]
Roth Mkm reissued their buy rating on shares of Iradimed (NASDAQ:IRMD – Free Report) in a report issued on Friday morning,Benzinga reports. The brokerage currently has a $72.00 price target on the medical equipment provider’s stock, up from their previous price target of $60.00. Separately, StockNews.com lowered shares of Iradimed from a “strong-buy” rating to […]
